ACA Pharma Named Exclusive Distributor for Ferabright™ in Macau, Hong Kong, Singapore, Greater Bay Area & Mainland China

ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop(R) System with Contrast Agents

(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain--the Swoop (R) system--today ...
Business Wire

Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...
News Medical

Advancements in MRI brain tumor segmentation with improved U-net model

The brain is responsible for the "general command" of human thinking and coordination of the body. Thus, various brain diseases can cause great damage to the human body and nervous system. Brain ...

Should You Get a Full-Body MRI? Doctors Warn Benefits May Not Outweigh the Hidden Risks

Full-body MRI scans are gaining popularity, but doctors warn their benefits may not outweigh the risks for healthy, symptom-free individuals. While MRIs can detect certain cancers and abnormalities, ...

ISMI Introduces a Radiologist-Led Full-Body MRI Program Focused on Diagnostic Clarity and Long-Term Health Planning

ISMI offers a radiologist-led Full-Body MRI in Montreal to identify life-saving findings, detect health risks, and support ...

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.